BI Asset Management Fondsmaeglerselskab A/S
Position in ELAN — Elanco Animal Health Inc
CIK 1778131
KOBENHAVN, G7
Position in ELAN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,236,187
+$244,758 QoQ
Shares Held
90,865
-32.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#188
of 518 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $42,638,294 across 9 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
306,576 | $22,030,551 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,597 | $6,825,432 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
33,211 | $5,597,381 | |
| 4 | VTRS |
Viatris Inc
|
150,504 | $2,390,003 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
90,865 | $2,236,187 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
54,001 | $1,829,553 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
39,832 | $1,634,306 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
544 | $60,351 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,236,187 | 90,865 | Shares | Defined | 2026-08-10 | |
| 2023-12-31 | $1,991,429 | 133,653 | Shares | Defined | 2024-02-09 | |
| 2023-03-31 | $29,995 | 3,191 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,482 | 776 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||